China Universal Asset Management Company’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $355K | Buy |
30,512
+910
| +3% | +$10.6K | 0.03% | 270 |
|
2025
Q1 | $220K | Sell |
29,602
-1,690
| -5% | -$12.6K | 0.02% | 306 |
|
2024
Q4 | $188K | Buy |
31,292
+2,928
| +10% | +$17.6K | 0.02% | 330 |
|
2024
Q3 | $145K | Buy |
28,364
+11,050
| +64% | +$56.6K | 0.02% | 324 |
|
2024
Q2 | $62.7K | Sell |
17,314
-10,582
| -38% | -$38.3K | 0.01% | 340 |
|
2024
Q1 | $89.5K | Buy |
27,896
+11,149
| +67% | +$35.8K | 0.01% | 381 |
|
2023
Q4 | $82.1K | Buy |
16,747
+13,028
| +350% | +$63.8K | 0.02% | 308 |
|
2023
Q3 | $20.3K | Buy |
3,719
+1,828
| +97% | +$9.96K | 0.01% | 296 |
|
2023
Q2 | $12.7K | Sell |
1,891
-49
| -3% | -$329 | ﹤0.01% | 305 |
|
2023
Q1 | $17.1K | Buy |
1,940
+487
| +34% | +$4.3K | 0.01% | 235 |
|
2022
Q4 | $11.1K | Buy |
1,453
+115
| +9% | +$879 | ﹤0.01% | 220 |
|
2022
Q3 | $10K | Buy |
+1,338
| New | +$10K | ﹤0.01% | 202 |
|